Microbiology & Toxicology Testing
Wickham Laboratories is a GMP/GLP compliant laboratory with over 50 years of global experience in specialised pharmaceutical and medical device testing in the fields of microbiology and toxicology. Conducting business with clients worldwide, we have the capability to offer solutions to microbiology development projects from early stage to product release as well as routine product testing and toxicology services.
Our approach is to listen and understand your outsourcing requirement, and then translate this information into an effective plan to fully address your testing needs. Using harmonised methods compliant with Ph. Eur, USP, JP and ISO standards, the combined expertise of our laboratory technicians and managers enables us to be fully conversant with regulatory expectations.
Our mission is to be the partner of choice for contract research outsourcing and we aim to offer only the highest possible level of quality and standards for our customers. We are routinely inspected by the MHRA and FDA as well as other global regulatory authorities, and offer the opportunity for clients to conduct audits on a regular basis. We are proud of how our services are recognised in the industry and our ability to deliver consistent, high quality testing no matter what the laboratory discipline.
Contact Details:
Company name: Wickham Laboratories Limited
Website: www.wickhamlabs.co.uk
E-mail: mail@wickhamlabs.co.uk
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
